FCMV

Foresite Capital Management VI Portfolio holdings

AUM $178M
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$178M
AUM Growth
-$4.66M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
20
New
Increased
Reduced
Closed

Top Buys

1
+$6.99M
2
+$5.3M
3
+$5.01M
4
IDYA icon
IDEAYA Biosciences
IDYA
+$3.04M
5
RNA icon
Avidity Biosciences
RNA
+$1.14M

Top Sells

1
+$6.41M
2
+$4.36M
3
+$647K
4
CASI icon
CASI Pharmaceuticals
CASI
+$640K
5
CGEM icon
Cullinan Oncology
CGEM
+$305K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGON icon
1
CG Oncology
CGON
$3.38B
$57.8M 32.47%
2,221,474
CNTA
2
Centessa Pharmaceuticals
CNTA
$3.28B
$16.5M 9.26%
1,253,379
AKRO icon
3
Akero Therapeutics
AKRO
$4.32B
$13.1M 7.35%
244,900
-120,100
ALMS
4
Alumis Inc
ALMS
$501M
$12.7M 7.16%
4,247,670
+45,000
RAPT icon
5
RAPT Therapeutics
RAPT
$749M
$12.5M 7.03%
1,562,500
BCAX
6
Bicara Therapeutics
BCAX
$928M
$8.82M 4.96%
949,260
-740
EWTX icon
7
Edgewise Therapeutics
EWTX
$1.69B
$7.67M 4.31%
585,000
HNGE
8
Hinge Health
HNGE
$3.91B
$6.99M 3.93%
+135,000
CRVS icon
9
Corvus Pharmaceuticals
CRVS
$586M
$6.92M 3.89%
1,731,233
+150,000
KYMR icon
10
Kymera Therapeutics
KYMR
$4.35B
$6.39M 3.59%
146,332
VSTM icon
11
Verastem
VSTM
$537M
$5.3M 2.98%
+1,276,520
XENE icon
12
Xenon Pharmaceuticals
XENE
$3.23B
$5.01M 2.82%
+160,000
CGEM icon
13
Cullinan Oncology
CGEM
$476M
$4.47M 2.51%
594,025
-40,533
GPCR icon
14
Structure Therapeutics
GPCR
$1.65B
$4.36M 2.45%
210,000
-210,000
ALLO icon
15
Allogene Therapeutics
ALLO
$273M
$3.25M 1.83%
2,875,357
-572,918
IDYA icon
16
IDEAYA Biosciences
IDYA
$2.84B
$3.04M 1.71%
+144,468
RNA icon
17
Avidity Biosciences
RNA
$10.2B
$1.14M 0.64%
+40,000
SYRE icon
18
Spyre Therapeutics
SYRE
$1.9B
$1.05M 0.59%
+70,000
CASI icon
19
CASI Pharmaceuticals
CASI
$25.1M
$929K 0.52%
787,121
-542,262
VRDN icon
20
Viridian Therapeutics
VRDN
$2.1B
$27.6K 0.02%
1,974